Dermira launching Qbrexza for primary axillary hyperhidrosis

Dermira Inc. (NASDAQ:DERM) will launch Qbrexza glycopyrronium tosylate to treat

Read the full 107 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE